Please sign in to follow a disease.
Yana Najjar
Clinical trials sponsored by Yana Najjar, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can radiation plus two immunotherapies shrink Hard-to-Treat tumors? Results expected Oct 2026 (estimated)
-
Virus injection aims to stop melanoma before it spreads
Disease control Recruiting nowThis early-phase study tests an injection of a modified herpes virus (RP1) directly into high-risk melanoma tumors. The goal is to see if it can kill cancer cells and reduce the chance of the cancer spreading to nearby lymph nodes. About 25 adults with thick or ulcerated melanoma…
Early phase 1 • Sponsor: Yana Najjar • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Scientists track Melanoma's metabolic tricks in tiny study
Knowledge-focused Recruiting nowThis study looks at melanoma tumors that spread between the main tumor and nearby lymph nodes (called in-transit metastases). Researchers will take biopsies from different spots and use a safe tracer to measure oxygen levels. They aim to understand how these tumors change metabol…
Sponsor: Yana Najjar • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Oxygen levels in melanoma may predict cancer spread
Knowledge-focused Recruiting nowThis study is investigating whether low oxygen levels (hypoxia) in melanoma tumors and nearby lymph nodes are linked to worse outcomes. Researchers will give 50 patients a safe oral tracer called pimonidazole before their standard surgery. By measuring hypoxia in the removed tiss…
Sponsor: Yana Najjar • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC